CVE-2023-34345

CVE-2023-34345 is a medium-severity vulnerability in Ami Megarac Sp-x with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-22.

Key facts

Description

AMI BMC contains a vulnerability in the SPX REST API, where an attacker with the required privileges can access arbitrary files, which may lead to information disclosure.

Frequently asked questions

What is CVE-2023-34345?
AMI BMC contains a vulnerability in the SPX REST API, where an attacker with the required privileges can access arbitrary files, which may lead to information disclosure.
How severe is CVE-2023-34345?
CVE-2023-34345 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2023-34345 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (49th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-34345?
CVE-2023-34345 affects Ami Megarac Sp-x. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-34345?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2023-34345 published?
CVE-2023-34345 was published on 2023-06-12 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Ami Megarac Sp-x

All CVEs affecting Ami Megarac Sp-x →

Other CWE-22 (Path Traversal) vulnerabilities

Browse all CWE-22 (Path Traversal) vulnerabilities →